DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $35.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price reduced by research analysts at Evercore ISI from $40.00 to $35.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the medical instruments supplier’s stock. Evercore ISI’s price objective would indicate a potential upside of 23.72% from the company’s current price.

Several other research analysts have also issued reports on the stock. Needham & Company LLC decreased their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research note on Friday. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. SVB Leerink initiated coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Finally, Barrington Research lowered their price target on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a research report on Friday. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $36.90.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $28.29 on Friday. The company has a 50-day simple moving average of $32.13 and a two-hundred day simple moving average of $32.71. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.95 and a current ratio of 1.43. DENTSPLY SIRONA has a one year low of $26.27 and a one year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.39 EPS. Research analysts anticipate that DENTSPLY SIRONA will post 2.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. VisionPoint Advisory Group LLC grew its position in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares during the period. Principal Securities Inc. bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. Headlands Technologies LLC purchased a new stake in DENTSPLY SIRONA during the fourth quarter valued at $30,000. Parkside Financial Bank & Trust lifted its holdings in DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 292 shares during the period. Finally, Anchor Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at about $47,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.